UY27653A1 - Derivados de fenilglicina solubles en agua - Google Patents
Derivados de fenilglicina solubles en aguaInfo
- Publication number
- UY27653A1 UY27653A1 UY27653A UY27653A UY27653A1 UY 27653 A1 UY27653 A1 UY 27653A1 UY 27653 A UY27653 A UY 27653A UY 27653 A UY27653 A UY 27653A UY 27653 A1 UY27653 A1 UY 27653A1
- Authority
- UY
- Uruguay
- Prior art keywords
- derivatives
- phenylglycin
- water soluble
- soluble
- carbamimidoyl
- Prior art date
Links
- ZGUNAGUHMKGQNY-UHFFFAOYSA-N alpha-phenylglycine Chemical class OC(=O)C(N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-UHFFFAOYSA-N 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title 1
- LXUXHIBNHAQIJI-UHFFFAOYSA-N 2-(4-carbamimidoylanilino)acetic acid Chemical class NC(=N)C1=CC=C(NCC(O)=O)C=C1 LXUXHIBNHAQIJI-UHFFFAOYSA-N 0.000 abstract 1
- 108010039209 Blood Coagulation Factors Proteins 0.000 abstract 1
- 102000015081 Blood Coagulation Factors Human genes 0.000 abstract 1
- 108010054265 Factor VIIa Proteins 0.000 abstract 1
- 108090000190 Thrombin Proteins 0.000 abstract 1
- 108010000499 Thromboplastin Proteins 0.000 abstract 1
- 102000002262 Thromboplastin Human genes 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000003114 blood coagulation factor Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940012414 factor viia Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229960004072 thrombin Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
- Peptides Or Proteins (AREA)
- Pyridine Compounds (AREA)
Abstract
El invento se refiere a nuevos derivados de N- (4 - carbamimidoil- fenil) - glicina acuosolubles de fórmula (I) en donde R1 A R4 y n son como se ha definido en la descripción y en las reivindicaciones, así como sus sales fisiológicamente aceptable. Estos compuestos inhiben la formación de factores de coagulación Xa, IXa y trombina inducido por factor VIIa y factor tisular y pueden utilizarse como medicamentos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02002009 | 2002-02-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY27653A1 true UY27653A1 (es) | 2003-08-29 |
Family
ID=27675597
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY27653A UY27653A1 (es) | 2002-02-06 | 2003-02-05 | Derivados de fenilglicina solubles en agua |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6642386B2 (es) |
| EP (1) | EP1474391A1 (es) |
| JP (1) | JP2005522435A (es) |
| KR (1) | KR20040082411A (es) |
| CN (1) | CN1628099A (es) |
| AR (1) | AR038480A1 (es) |
| AU (1) | AU2003244474B2 (es) |
| BR (1) | BR0307469A (es) |
| CA (1) | CA2474027A1 (es) |
| GT (1) | GT200300030A (es) |
| JO (1) | JO2241B1 (es) |
| MX (1) | MXPA04007500A (es) |
| PA (1) | PA8564801A1 (es) |
| PE (1) | PE20030905A1 (es) |
| PL (1) | PL372197A1 (es) |
| RU (1) | RU2283305C2 (es) |
| TW (1) | TW200303744A (es) |
| UY (1) | UY27653A1 (es) |
| WO (1) | WO2003066588A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE274491T1 (de) * | 1998-12-14 | 2004-09-15 | Hoffmann La Roche | Phenylglycin-derivate |
| JP2006517589A (ja) | 2003-02-11 | 2006-07-27 | ブリストル−マイヤーズ スクイブ カンパニー | セリンプロテアーゼ・インヒビターとして有用なベンゼンアセトアミド化合物 |
| US7122559B2 (en) | 2003-02-11 | 2006-10-17 | Bristol-Myers Squibb Company | Phenylglycine derivatives useful as serine protease inhibitors |
| ES2349428T3 (es) | 2005-01-10 | 2011-01-03 | Bristol-Myers Squibb Company | Derivados de fenilglicinamida útiles como anticoagulantes. |
| ES2337831T3 (es) * | 2005-06-24 | 2010-04-29 | Bristol-Myers Squibb Company | Derivados de fenilglicinamida y piridilclicinamida utiles como agentes anticoagulantes. |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE274491T1 (de) | 1998-12-14 | 2004-09-15 | Hoffmann La Roche | Phenylglycin-derivate |
| US6548694B2 (en) | 2000-05-23 | 2003-04-15 | Hoffman-La Roche Inc. | N-(4-carbamimidoyl-phenyl)-glycine derivatives |
-
2003
- 2003-01-24 US US10/350,617 patent/US6642386B2/en not_active Expired - Fee Related
- 2003-01-30 RU RU2004126940/04A patent/RU2283305C2/ru not_active IP Right Cessation
- 2003-01-30 WO PCT/EP2003/000937 patent/WO2003066588A1/en not_active Ceased
- 2003-01-30 KR KR10-2004-7012096A patent/KR20040082411A/ko not_active Ceased
- 2003-01-30 BR BR0307469-2A patent/BR0307469A/pt not_active IP Right Cessation
- 2003-01-30 AU AU2003244474A patent/AU2003244474B2/en not_active Ceased
- 2003-01-30 CA CA002474027A patent/CA2474027A1/en not_active Abandoned
- 2003-01-30 JP JP2003565963A patent/JP2005522435A/ja active Pending
- 2003-01-30 MX MXPA04007500A patent/MXPA04007500A/es unknown
- 2003-01-30 CN CNA038032619A patent/CN1628099A/zh active Pending
- 2003-01-30 EP EP03737293A patent/EP1474391A1/en not_active Withdrawn
- 2003-01-30 PL PL03372197A patent/PL372197A1/xx not_active Application Discontinuation
- 2003-02-02 JO JO200311A patent/JO2241B1/en active
- 2003-02-03 PA PA20038564801A patent/PA8564801A1/es unknown
- 2003-02-03 PE PE2003000123A patent/PE20030905A1/es not_active Application Discontinuation
- 2003-02-04 GT GT200300030A patent/GT200300030A/es unknown
- 2003-02-04 AR ARP030100333A patent/AR038480A1/es unknown
- 2003-02-05 UY UY27653A patent/UY27653A1/es not_active Application Discontinuation
- 2003-02-06 TW TW092102394A patent/TW200303744A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PA8564801A1 (es) | 2003-12-10 |
| BR0307469A (pt) | 2004-11-09 |
| TW200303744A (en) | 2003-09-16 |
| WO2003066588A1 (en) | 2003-08-14 |
| RU2283305C2 (ru) | 2006-09-10 |
| US20030166683A1 (en) | 2003-09-04 |
| CN1628099A (zh) | 2005-06-15 |
| US6642386B2 (en) | 2003-11-04 |
| AR038480A1 (es) | 2005-01-19 |
| AU2003244474A1 (en) | 2003-09-02 |
| JO2241B1 (en) | 2004-10-07 |
| RU2004126940A (ru) | 2005-08-10 |
| AU2003244474B2 (en) | 2006-05-11 |
| GT200300030A (es) | 2003-09-12 |
| PL372197A1 (en) | 2005-07-11 |
| PE20030905A1 (es) | 2003-11-08 |
| CA2474027A1 (en) | 2003-08-14 |
| JP2005522435A (ja) | 2005-07-28 |
| EP1474391A1 (en) | 2004-11-10 |
| KR20040082411A (ko) | 2004-09-24 |
| MXPA04007500A (es) | 2004-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY28090A1 (es) | Derivados de acido mandelico | |
| UY26721A1 (es) | Nuevos derivados de la fenilglicina | |
| ECSP066493A (es) | Combinaciones sinérgicas de productos activos, fungicidas | |
| BRPI0412851A (pt) | benzamidazóis de n-metila-substituìdos | |
| EA200600223A1 (ru) | Замещённый 2-аминотетралины для лечения депрессии | |
| CY1106375T1 (el) | Χρηση της επιγαστινης για την αντιμετωπιση αλλepγικης ρινιτιδας/επιπεφυκιτιδας | |
| ECSP055531A (es) | "nuevos derivados de glicósido de tiofeno, metodos para la preparacion de los mismos, medicamentos que comprenden dichos compuestos, y su uso" | |
| CY1116103T1 (el) | Υποκατεστημενα παραγωγα 1,2,3,4-τετραϋδροϊσοκινολινης | |
| ATE372767T1 (de) | Dpp-iv-hemmer | |
| CY1105603T1 (el) | Συνεργιστικοι συνδυασμοι που περιλαμβανουν εναν αναστολεα της ρενινης, για καρδιαγγειακες νοσους | |
| SE0302760D0 (sv) | New compounds | |
| ATE440834T1 (de) | Substituierte arylaminderivate und verwendungsverfahren | |
| TW200720270A (en) | Novel cyclic amines | |
| NO20070089L (no) | DPP-IV inhibitorer | |
| NO20075637L (no) | 4-fenyl-5-okso-1,4,5,6,7,8-heksahydrokinolinderivater som medikamenter for behandling av infertilitet | |
| ATE308540T1 (de) | Antithrombosemittel | |
| UY27653A1 (es) | Derivados de fenilglicina solubles en agua | |
| NO20072247L (no) | Nye dikarboksamid-derivater. | |
| EA200700997A1 (ru) | 2,5- и 2,6-дизамещенные аналоги бензазола, полезные в качестве ингибиторов протеинкиназ | |
| SE0203300D0 (sv) | Novel Compounds | |
| UY27034A1 (es) | Derivados de pirimidina | |
| BR0110255A (pt) | Cromenilmetil pirimidinadiaminas como agentes antibacterianos | |
| EA200300272A1 (ru) | Новые производные хиназолина, способ их получения и фармацевтические композиции, содержащие их | |
| DE60333578D1 (de) | Lamellarinanaloga mit antitumorwirkung | |
| AR048589A1 (es) | Derivados de pirrolidina -3,4-dicarboxamida |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20150428 |